Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Panel
titleEAM DISCUSSION

1: This is an example of a blinded study using double dummy packaging. Are these types of studies done?

2. The Weights are made up- we need team help in  providing real weight amounts. 

3. The strength of the cartridge- WE see these like Joules says 5% , while other use mg/ML. What should be used, as a measure of the strength.    

In this study, subjects were randomized were randomized to either nicotine replacement patches or ENDsENDS devices using e-nicotine liquid cartridges. In order to maintain the blind, subjects used both the nicotine replacement patches and the ENDS devicedevices. Subjects were requested not to smoke, but the number of regular cigarettes used were collected. Subject were seen every day for 15 days. The nicotine patch was applied at  , at rotating sites, and the ENDS nicotine cartridge was replaced every day. The cartridge was weight weighed when dispended dispensed and upon return. On days, 1, 5, and 10 subjects remained in the clinic for 4 hours for collection of biomarkers.   On these days, a new ENDS nicotine cartridge device was inserted and then used for 10 puffs were taken over 10 minutes, and then not used for 4 hoursthe remaining collection period. A new cartridge was insert inserted at the end of the 4 hours. The  -hour collection period. A nicotine replacement patch was applied prior to using the ENDS device on these days.        

The SU domain was used to represent the number of cigarettes used, but is not shown.  

In this study,   the weight of the contents in the cartridges were being accounted for, as well as the number of patches.  A Product Accountability (DA) domain was submitted cartridge was tracked. The DA domain was used to represent dispensed and returned amounts. Each cartridge had a uniquely assigned number. The sponsor used DAREFID  that appeared on the label to identify the cartridge.  Multiple cartridges were dispensed at weekly visits, but each cartridge was tracked. At each weekly visit, all previously dispended cartridges were returned, and new cartridges dispensed.  Cartridges were replaced at each visit. DADTC are the visit dates when the cartridge was returned or dispensed.  A returned cartridges that was not used was recorded as having weight of the dispensed cartridges,   NOTE ;  A REAL EXAMPLE FROM A SPONOSR WOULD BE HELPFUL. THESE ARE MADE UP AMOUNTS. NEED TO ENSURE EXPOSURE NUMBERS MATCH THESE WEIGHTS:weights of each cartridge. Only a few rows are shown. The product accountability information was not provided for the nicotine replacement patches.    

Dataset wrap
Dataset2
RowSTUDYIDDOMAINUSUBJIDDASEQDAREFIDDATESTCDDATESTDACATDASCATDAORRESDAORRESUDASTRESCDASTRESNDASTRESUDASTATDAREASNDVISITNUMDADTC
1ABCTEDP07DAABC-0100110001

1

CRT8754DISPAMTDispensed AmountSTUDY PRODUCTE-LIQUID25.3g2525g12004-06-2606
2ABCTEDP07DAABC-0100110001

2

CRT8768CRT8754DISPAMTRETAMTDispensed Returned AmountSTUDY PRODUCTE-LIQUID2325g25232523g120042020-06-2606
3ABCTEDP07DAABC-0100110001

3

CRT8769CRT9756DISPAMTDispensed AmountSTUDY PRODUCTE-LIQUID25.1g2525g120042020-06-2607
4ABCTEDP07DAABC-0100110001

4

CRT8754CRT9756RETAMTReturned AmountSTUDY PRODUCTNOT DONESubject forgot to return the cartridge2020-07-06E-LIQUID10g14145ABCDAABC-01001

5

CRT8768RETAMTReturned AmountSTUDY PRODUCT24g2424g22020-07-066ABCDAABC-01001

6

CRT8769RETAMTReturned AmountSTUDY PRODUCT10g1010-08
5TEDP07DA10001

5

CRT9955g22020-07-067ABCDAABC-01001

7

CRT9756DISPAMTDispensed AmountSTUDY PRODUCTE-LIQUID25.2g2525g22020-072004-068ABCDAABC-01001

8

CRT9756RETAMTReturned AmountSTUDY PRODUCT14g14143g32020-07-109ABCDAABC-01001

4

CRT8754RETAMTReturned AmountSTUDY PRODUCT10g1010g32020-07-06-08

EC was used to represent the collected exposure data since a double dummy -blind design was used. The EX domain  domain was used to represent the subject's exposure to the actual product containing nicotine. The applicant represented each cartridge and patch used. The dose was represented as "1" to indicate 1 cartridge or patch.       The actual date and specific time of usage of the cartridge was recorded on days 1, 5, and 10, while only the date of usage was recorded on other days.           

Dataset wrap
Nameec
TREATMENT
Dataset2

Row

STUDYID

DOMAIN

USUBJID

ECSEQ

ECTRT

ECDOSE

ECDOSTXT

ECDOSU

ECDOSFRM

ECROUTE

ECFREQ

ECLOCECLATECDIREPOCH

ECSTDTC

ECENDTC

1TEDP07EC10001 1ENDS  
1
10
CONTAINER

PUFF
INHALEDONCE
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE2020-06-
01T8
01T08:002020-06-
01T
01T08:
8:
10
2TEDP07EC10001 2

 PATCH 

1
PATCHPATCHTRANSDERMALARMRIGHTUPPER
TREATMENT
PRODUCT EXPOSURE2020-06-012020-06-02
3TEDP07EC10001 3ENDS 
1

AD LIBITUM
CONTAINER
PUFF
INHALEDAD LIBITUM
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE
TREATMENT
2020-06-
01
01T12:
T12:
102020-06-02
4TEDP07EC10001 
1
4ENDS  
1

AD LIBITUM
CONTAINER
PUFF
INHALEDAD LIBITUMTREATMENT
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE2020-06-022020-06-
02
03
5TEDP07EC10001
1
5
 PATCH 
PATCH 1
PATCHPATCHTRANSDERMALARMLEFTUPPER
TREATMENT
PRODUCT EXPOSURE2020-06-022020-06-03
6TEDP07EC10001
2
6ENDS 
1

AD LIBITUM
CONTAINER
PUFF
INHALEDAD LIBITUM
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE
TREATMENT
2020-06-032020-06-
03
04
7TEDP07EC10001
3
7
 PATCH 
PATCH 1
PATCHPATCHTRANSDERMALLEGLEFTUPPER
TREATMENT
PRODUCT EXPOSURE2020-06-032020-06-04
7TEDP07EC10001 
4
8ENDS 
1

AD LIBITUM
CONTAINER
PUFF
INHALEDAD LIBITUMTREATMENT
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE2020-06-042020-06-05
8TEDP07EC10001 
5
9
 PATCH 
PATCH 1
PATCHPATCHTRANSDERMALLEGLEFTLOWER
TREATMENT
PRODUCT EXPOSURE2020-06-042020-06-05
9TEDP07EC10001
6
10ENDS 
1
10
CONTAINER

PUFF
INHALEDONCE
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE
TREATMENT
2020-06-
T09;8
10T8:302020-06-
T09;8
10T8:40
10TEDP07EC10001
7
11 PATCH 1
PATCH PATCH TRANSDERMALLEGRIGHTLOWER
TREATMENT
PRODUCT EXPOSURE2020-06-102020-06-11
11TEDP07EC10001
8
12ENDS 
1

AD LIBITUM
CONTAINER
PUFF
INHALEDAD LIBITUM
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE
TREATMENT
2020-06-
10
10T12:
T12:
402020-06-11

TIME FORMATS NEED TO BE FIXED  Subject 10001 was randomized to the 5% pharmaceutical strength of the nicotine e-liquid, and subject 20001 was randomized to the nicotine patch with a pharmaceutical strength of 14mg. The applicant only represented the active product exposure for each subject in EX.

Dataset wrap
Nameex
Dataset2

Row

STUDYID

DOMAIN

USUBJID

EXSEQ

EXTRT

EXDOSE

EXDOSU

EXDOSFRM

EXROUTE

EXFREQ
EXLOCEXLATEXDIREPOCH

EXPSTRG

EXPSTRGU

ECSTDTC

EXSTDTC

ECENDTC

EXENDTC

1TEDP07EX10001 1
ENDS  
e nicotine liquid 1.7
3
g
INHALEDONCETREATMENT
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE5%2020-06-
01
01T08:
T8:
002020-06-
01
01T:8:10
2TEDP07EX10001 2
ENDS 
e nicotine liquid 15.1g
INHALEDAD LIBITUMTRE5ATMENT
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE5%2020-06-
01
01T12:
T8:
102020-06-02
3TEDP07EX10001 3
ENDS  
e nicotine liquid 13g
INHALEDAD LIBITUM
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE5%
TREATMENT
2020-06-022020-06-
02
03
4TEDP07EX100014
ENDS 
e nicotine liquid 12g
INHALEDAD LIBITUM
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE5%
TREATMENT
2020-06-032020-06-
03
04
5TEDP07EX10001 5
ENDS 
e nicotine liquid 9g
INHALED
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE5%
AD LIBITUMTREATMENT
2020-06-042020-06-05
6TEDP07EX100016
ENDS 
e nicotine liquid 7g
INHALEDONCE
CARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE5%
TREATMENT
2020-06-
09T8
10T08:302020-06-
09T8
10T08:40
7TEDP07EX100017
ENDS 
e nicotine liquid 5
mgINHALEDAD LIBITUM
gCARTRIDGERESPIRATORY (INHALATION)


PRODUCT EXPOSURE5%
TREATMENT
2020-06-
10T
10T12:
:240
402020-06-11
8TEDP07
EC
EX
10001 
20001 1
 PATCH 

nicotine replacement therapy

1PATCHPATCHTRANSDERMAL
QD
ARMRIGHTUPPER
TREATMENT
PRODUCT EXPOSURE14mg2020-06-012020-06-02
9TEDP07
EC
EX200012
 PATCH 
nicotine replacement therapy1PATCHPATCHTRANSDERMAL
QD
ARMLEFTUPPER
TREATMENT
PRODUCT EXPOSURE14mg2020-06-022020-06-03
10TEDP07
EC
EX200013
 PATCH 
nicotine replacement therapy1PATCHPATCHTRANSDERMAL
QD
LEGLEFTUPPER
TREATMENT
PRODUCT EXPOSURE14mg2020-06-032020-06-04
11TEDP07
EC
EX20001 4
 PATCH 
nicotine replacement therapy1PATCHPATCHTRANSDERMAL
QD
LEGLEFTLOWER
TREATMENT
PRODUCT EXPOSURE14mg2020-06-042020-06-05
12TEDP07
EC
EX20001
7
5
 PATCH 
nicotine replacement therapy1PATCH PATCHTRANSDERMAL
QD
LEGRIGHTLOWER
TREATMENT
PRODUCT EXPOSURE14mg2020-06-102020-06-11